CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism

Chemoresistance against 5-fluorouracil (5-FU) is a major issue for colorectal cancer (CRC) patients. Increasing evidence for the roles of CD147 in glycolipid metabolic reprogramming and chemoresistance of tumor cells has emerged in recent years. However, whether CD147 contributes to 5-FU resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuohui, Li, Songhan, Wang, Xiaoyan, Liang, Shuo, Zhang, Wenjie, Li, Linchuan, Xu, Qian, Shi, Bowen, Cheng, Zhiqiang, Zhang, Xiang, Zhong, Mingwei, Zhang, Guangyong, Hu, Sanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309564/
https://www.ncbi.nlm.nih.gov/pubmed/35898887
http://dx.doi.org/10.3389/fonc.2022.813852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309564/
https://www.ncbi.nlm.nih.gov/pubmed/35898887
http://dx.doi.org/10.3389/fonc.2022.813852

Ejemplares similares